Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu
✦ LIBER ✦
Cytological grading of therapy-induced tumor regression in prostatic carcinoma: Proposal of a new system
✍ Scribed by Alfred Böcking; Wolfgang Auffermann
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 442 KB
- Volume
- 3
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
✦ Synopsis
Proposed in this article is a new system for the cytological grading of therapy-induced regression of prostatic carcinoma. Reversible and irreversible criteria in cytoplasm, nuclei, and nucleoli are distinguished and rated independently of each other on a scale of 0 to 2; the cellular regression grades r1-r3 are the sum of rating numbers. Criteria that are invalid for grading regression are pointed out. Results of the clinical testing of this grading system are presented.
📜 SIMILAR VOLUMES
IL-12- and IL-2-induced tumor regression
✍
Giovana R. Thomas; Zhong Chen; Ileana Enamorado; Caren Bancroft; Carter Van Waes
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
French
⚖ 313 KB
👁 2 views